Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Recon Capital Nasdaq-100 Covere | QYLD | Oct 31, 2024 | 17.97 | -1.32 |
Recon Technology | RCON | Oct 31, 2024 | 2.27 | +2.25 |
Recruiter.com Group | RCRT | Oct 31, 2024 | 2.74 | 0.00 |
Rectitude Holdings | RECT | Oct 31, 2024 | 3.20 | -4.16 |
Recursion Pharmaceuticals A | RXRX | Oct 31, 2024 | 6.32 | -5.39 |
Red Cat | RCAT | Oct 31, 2024 | 3.06 | -3.47 |
Red River Bancshares | RRBI | Oct 31, 2024 | 52.22 | -1.40 |
Red Robin Gourmet Burgers | RRGB | Oct 31, 2024 | 5.71 | -5.46 |
Red Rock Resorts A | RRR | Oct 31, 2024 | 51.46 | -3.09 |
Red Violet | RDVT | Oct 31, 2024 | 30.08 | +0.03 |
RDDT | Oct 31, 2024 | 119.30 | +2.80 | |
Redfin | RDFN | Oct 31, 2024 | 10.37 | +0.48 |
RedHill Biopharma ADR | RDHL | Oct 31, 2024 | 8.24 | -1.20 |
Redwire | RDW | Oct 31, 2024 | 7.69 | -2.66 |
Redwood Trust | RWT-A | Oct 31, 2024 | 26.02 | 0.00 |
Redwood Trust | RWT | Oct 31, 2024 | 7.32 | -4.19 |
REE Automotive A | REE | Oct 31, 2024 | 7.15 | -2.99 |
Regal Rexnord | RRX | Oct 31, 2024 | 166.54 | -1.48 |
Regency Centers | REG | Oct 31, 2024 | 71.44 | -1.73 |
Regency Centers A Pref | REGCP | Oct 31, 2024 | 25.05 | +1.21 |
Regency Centers B Pref | REGCO | Oct 31, 2024 | 24.43 | +0.74 |
Regeneron Pharmaceuticals | REGN | Oct 31, 2024 | 838.20 | -9.17 |
REGENXBIO | RGNX | Oct 31, 2024 | 8.59 | -2.83 |
Regional Health Properties | RHE | Oct 31, 2024 | 1.75 | -2.78 |
Regional Health Properties A Pref | RHE-A | Oct 31, 2024 | 0.52 | -3.70 |
Regional Management | RM | Oct 31, 2024 | 28.72 | -0.83 |
Regions Financial | RF | Oct 31, 2024 | 23.87 | -0.79 |
Regions Financial B Pref | RF-B | Oct 31, 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Oct 31, 2024 | 25.14 | +0.20 |
Regions Financial E Pref | RF-E | Oct 31, 2024 | 19.19 | -1.34 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.